Toxic metabolite formation from Troglitazone (TGZ): new insights from a DFT study - PubMed (original) (raw)
. 2011 Jul 18;24(7):1113-22.
doi: 10.1021/tx200110h. Epub 2011 Jun 21.
Affiliations
- PMID: 21657230
- DOI: 10.1021/tx200110h
Toxic metabolite formation from Troglitazone (TGZ): new insights from a DFT study
Vaibhav A Dixit et al. Chem Res Toxicol. 2011.
Abstract
The hepatotoxicity of Troglitazone (TGZ) has been ascribed to the formation of reactive metabolites, and the primary reactive metabolite of TGZ has been confirmed to be an o-quinone methide. Oxidation of the chromane moiety is also known to produce quinone containing metabolites. Quantum chemical studies have been performed to analyze the possible reaction pathways for the metabolism of the TGZ side chain, 6-hydroxy-2,2,5,7,8-pentamethylchromane (HPMC). From this analysis, a new pathway including oxidation at the C13 and C14 atoms of HPMC has been proposed for the formation of o-quinone methide (M2), while oxidation at the hydroxyl group leads to the formation of the quinone metabolite (M7). o-Quinone methide reactive metabolites have been shown to be more electrophilic at the reactive methylene center using quantum chemically estimated parameters.
© 2011 American Chemical Society
Similar articles
- Electrochemical oxidation of troglitazone: identification and characterization of the major reactive metabolite in liver microsomes.
Madsen KG, Grönberg G, Skonberg C, Jurva U, Hansen SH, Olsen J. Madsen KG, et al. Chem Res Toxicol. 2008 Oct;21(10):2035-41. doi: 10.1021/tx8002214. Epub 2008 Sep 13. Chem Res Toxicol. 2008. PMID: 18788755 - Incorporation of an oxygen from water into troglitazone quinone by cytochrome P450 and myeloperoxidase.
He K, Talaat RE, Woolf TF. He K, et al. Drug Metab Dispos. 2004 Apr;32(4):442-6. doi: 10.1124/dmd.32.4.442. Drug Metab Dispos. 2004. PMID: 15039298 - Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo.
Tettey JN, Maggs JL, Rapeport WG, Pirmohamed M, Park BK. Tettey JN, et al. Chem Res Toxicol. 2001 Aug;14(8):965-74. doi: 10.1021/tx0001981. Chem Res Toxicol. 2001. PMID: 11511170 - Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review.
Masubuchi Y. Masubuchi Y. Drug Metab Pharmacokinet. 2006 Oct;21(5):347-56. doi: 10.2133/dmpk.21.347. Drug Metab Pharmacokinet. 2006. PMID: 17072088 Review. - Ontology-based knowledge management of troglitazone-induced hepatotoxicity.
Hug H, Dannecker R, Schindler R, Bagatto D, Stephan A, Wess RA, Gut J. Hug H, et al. Drug Discov Today. 2004 Nov 15;9(22):948-54. doi: 10.1016/S1359-6446(04)03252-0. Drug Discov Today. 2004. PMID: 15539136 Review. No abstract available.
Cited by
- Natural 6-hydroxy-chromanols and -chromenols: structural diversity, biosynthetic pathways and health implications.
Birringer M, Siems K, Maxones A, Frank J, Lorkowski S. Birringer M, et al. RSC Adv. 2018 Jan 26;8(9):4803-4841. doi: 10.1039/c7ra11819h. eCollection 2018 Jan 24. RSC Adv. 2018. PMID: 35539527 Free PMC article. Review. - Computer-Aided Estimation of Biological Activity Profiles of Drug-Like Compounds Taking into Account Their Metabolism in Human Body.
Filimonov DA, Rudik AV, Dmitriev AV, Poroikov VV. Filimonov DA, et al. Int J Mol Sci. 2020 Oct 11;21(20):7492. doi: 10.3390/ijms21207492. Int J Mol Sci. 2020. PMID: 33050610 Free PMC article. - A simple model to solve a complex drug toxicity problem.
Dixit VA. Dixit VA. Toxicol Res (Camb). 2018 Nov 29;8(2):157-171. doi: 10.1039/c8tx00261d. eCollection 2019 Mar 1. Toxicol Res (Camb). 2018. PMID: 30997019 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources